ImClone (IMCL) Said Bristol-Myers' (BMY) Offer Substantially Undervalues The Company
Tweet Send to a Friend
ImClone Systems Incorporated (NASDAQ: IMCL) said its Board's preliminary view is that the $60 per share offer from Bristol-Myers Squibb ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
